On July 13 SandiJi (Nanjing) Pharmaceutical Technology Co. completed a new
strategic financing round. Investors include Shanghai Minhang District Financial
Investment Development Co. and Shanghai Lingang Digital Private Equity Fund
Management Co.; Hangzhou Industrial Investment Group Co. also participated and
will explore further strategic cooperation. Proceeds will fund a Shanghai
international R&D and manufacturing center, advance clinical development of
SandiJi’s oral-peptide pipeline and expand international collaboration. Yibo
served as exclusive financial adviser.
